Matrix metallopeptidase 14 mRNA 3'-untranslated region (MMP14 mRNA 3'-UTR)

The Matrix metallopeptidase 14 (MMP14) mRNA 3'-untranslated region (3'-UTR) is a key regulatory element that controls the expression of the MT1-MMP protein, a membrane-bound protease vital for extracellular matrix remodeling and cell signaling (UniProt: P50281). This region contains specific sequences recognized by various microRNAs (miRNAs), such as miR-181a-5p and miR-584, which act as post-transcriptional suppressors by inducing mRNA degradation or blocking translation (PubMed: 26066740). In pathological states, particularly in invasive cancers, the loss of miRNA-mediated control at this 3'-UTR often leads to the overexpression of MMP14 (PubMed: 24333729). Such overexpression facilitates tumor cell invasion, metastasis, and angiogenesis by degrading the basement membrane and activating other pro-tumorigenic factors (PubMed: 20577200). Therapeutic strategies targeting the MMP14 mRNA 3'-UTR involve the use of miRNA mimics or antisense oligonucleotides (ASOs) to restore regulatory control and reduce the proteolytic capacity of cancer cells. Understanding the structural and sequence motifs within this 3'-UTR is essential for developing precise RNA-targeted therapies that can mitigate the progression of aggressive malignancies. This target represents a significant focus in the field of epitranscriptomics and RNA-based drug discovery for oncology.

Other names

MT1-MMP mRNA 3'-UTRMembrane-type 1 matrix metalloproteinase mRNA 3'-UTRMMP-14 3'-UTRMatrix metalloproteinase-14 3'-untranslated region

Targeting the 3'-UTR via complementary base pairing (e.g., by microRNAs or antisense oligonucleotides) leads to the recruitment of the RNA-induced silencing complex (RISC) or steric hindrance, resulting in mRNA degradation or translational inhibition of the MMP14 transcript (PubMed: 26066740).